School of Pharmacy, University of Otago, PO Box 56, Dunedin, 9054, New Zealand.
Int J Clin Pharm. 2012 Apr;34(2):364-73. doi: 10.1007/s11096-012-9617-3. Epub 2012 Feb 23.
In recent years, the pharmacy profession has moved towards more patient-oriented services. Some examples are medication review, screening and monitoring for disease, and prescribing. The new services are intended to be in close collaboration with general practitioners (GPs) yet little is known of how GPs in New Zealand perceive these new services. Objective To examine GPs' perceptions of pharmacists' new services.
Study was undertaken at GPs' practices in two localities in New Zealand.
Qualitative, face to face, semi-structured interviews were undertaken of 18 GPs. The cohort included GPs with less/more than 20 years of practice, and GPs who had experience of working in localities where some patients had undergone a medication review (Medicines Use Review, MUR) by community pharmacists. GPs were asked to share their perceptions about pharmacists providing some new services. Data were thematically analysed with constant comparison using NVivo 8 software. Using a business strategic planning approach, themes were further analysed and interpreted as the services' potential Strengths, Weaknesses, Opportunities and Threats (SWOTs).
GPs' perceptions of pharmacists' new services.
GPs were more supportive of pharmacists' playing active roles in medication review and less supportive of pharmacists practising screening-monitoring and prescribing. Discussions Pharmacists' knowledge and skills in medication use and the perceived benefits of the services to patients were considered the potential strengths of the services. Weaknesses centred around potential patient confusion and harm, conflict and irritation to GPs' practice, and the potential to fragment patient-care. Opportunities were the possibilities of improving communication, and having a close collaboration and integration with GPs' practice. Apparent threats were the GPs' perceptions of a related, and not renumerated, increase in their workloads, and the perception of limited benefit to patients.
Pharmacists should exploit their own strengths and the potential opportunities for these services, and reduce any weaknesses and threats. A possible strategic plan should include increased effective communication, piloting services, and the integration of some services into medical practices.
近年来，药学专业朝着以患者为中心的服务方向发展。其中包括药物审查、疾病筛查和监测以及处方服务。这些新服务旨在与全科医生（GP）密切合作，但对于新西兰 GP 对这些新服务的看法知之甚少。目的：调查 GP 对药剂师新服务的看法。
在新西兰两个地方的 GP 诊所进行。
对 18 名 GP 进行了定性、面对面、半结构化访谈。该队列包括从业少于/多于 20 年的 GP，以及有过在一些患者接受社区药剂师进行药物审查（用药审查，MUR）的地区工作经验的 GP。要求 GP 分享他们对药剂师提供一些新服务的看法。使用 NVivo 8 软件进行恒定性比较的主题分析。采用商业战略规划方法，进一步分析和解释服务的潜在优势、劣势、机会和威胁（SWOT）。
GP 对药剂师新服务的看法。
GP 更支持药剂师在药物审查中发挥积极作用，而不太支持药剂师进行筛查-监测和处方服务。讨论：药剂师在药物使用方面的知识和技能以及服务对患者的潜在益处被认为是服务的潜在优势。劣势主要集中在潜在的患者困惑和伤害、对 GP 实践的冲突和刺激，以及患者护理碎片化的可能性。机遇在于改善沟通的可能性，以及与 GP 实践的密切合作和整合。明显的威胁是 GP 对相关但不报酬的工作量增加的看法，以及对患者收益的有限看法。
药剂师应利用自身优势和这些服务的潜在机会，减少劣势和威胁。可能的战略计划应包括增加有效沟通、服务试点和将一些服务纳入医疗实践。
